Ivermectin for Kidney Cancer: Patients Have Questions, Clinicians Have Concerns

(MedPage Today) — DENVER — A discussion about patient-centered issues in kidney cancer management focused considerable attention on the controversial antiparasitic ivermectin, which was not even on the program at the International Kidney Cancer…